Literature DB >> 10223961

Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.

M Brunner1, U Hollenstein, S Delacher, D Jäger, R Schmid, E Lackner, A Georgopoulos, H G Eichler, M Müller.   

Abstract

Interstitial ciprofloxacin concentrations in soft tissues were measured by microdialysis following intravenous administration of 200 mg to each of eight healthy volunteers. Interstitial ciprofloxacin concentrations were significantly lower than corresponding total serum drug concentrations; the interstitium-to-serum concentration ratios ranged from 0.55 to 0.73. An in vitro simulation based on interstitial pharmacokinetics showed a substantially lower antimicrobial activity than did the simulation based on serum pharmacokinetics. Thus, ciprofloxacin concentrations at the site of effect may be subinhibitory although effective concentrations are attained in serum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223961      PMCID: PMC89268     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Drug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in man.

Authors:  L Ståhle; P Arner; U Ungerstedt
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

2.  Drug distribution. The forgotten relative in clinical pharmacokinetics.

Authors:  H G Eichler; M Müller
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

3.  Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue.

Authors:  F D Daschner; M Westenfelder; A Dalhoff
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

4.  Treatment of skin and soft tissue infections with oral ciprofloxacin.

Authors:  R J Fass
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

Review 5.  Influence of binding on the pharmacologic activity of antibiotics.

Authors:  C M Kunin; W A Craig; M Kornguth; R Monson
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

6.  Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study.

Authors:  G D Fang; C Brennen; M Wagener; D Swanson; M Hilf; L Zadecky; J DeVine; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  A problem in the interpretation of beta-lactam antibiotic levels in tissues.

Authors:  D M Ryan; O Cars
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

8.  Effect of protein binding on antibiotic activity in vivo.

Authors:  D J Merrikin; J Briant; G N Rolinson
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

9.  Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection.

Authors:  C M Licitra; R G Brooks; B E Sieger
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

10.  Clinical experience with ciprofloxacin in the USA.

Authors:  G Arcieri; R August; N Becker; C Doyle; E Griffith; G Gruenwaldt; A Heyd; B O'Brien
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

View more
  20 in total

1.  Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.

Authors:  M Müller; M Brunner; U Hollenstein; C Joukhadar; R Schmid; E Minar; H Ehringer; H G Eichler
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Target site concentrations of ciprofloxacin after single intravenous and oral doses.

Authors:  Martin Brunner; Heino Stabeta; Jan-Georg Möller; Claudia Schrolnberger; Boban Erovic; Ursula Hollenstein; Markus Zeitlinger; Hans Georg Eichler; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 3.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

4.  Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue.

Authors:  Christian Joukhadar; Pejman Dehghanyar; Friederike Traunmüller; Robert Sauermann; Bernhard Mayer-Helm; Apostolos Georgopoulos; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

Authors:  Christian Joukhadar; Markus Müller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.

Authors:  Florian Islinger; Rene Bouw; Mathias Stahl; Edith Lackner; Petra Zeleny; Martin Brunner; Markus Müller; Hans Georg Eichler; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Electroporation and transcutaneous sampling (ETS) of acyclovir.

Authors:  S Narasimha Murthy; Shuangqing Zhang
Journal:  J Dermatol Sci       Date:  2007-10-18       Impact factor: 4.563

8.  Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.

Authors:  M Frossard; C Joukhadar; B M Erovic; P Dittrich; P E Mrass; M Van Houte; H Burgmann; A Georgopoulos; M Müller
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

9.  Tissue pharmacokinetics of levofloxacin in human soft tissue infections.

Authors:  Romuald Bellmann; Gerald Kuchling; Pejman Dehghanyar; Markus Zeitlinger; Erich Minar; Bernhard X Mayer; Markus Müller; Christian Joukhadar
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

10.  [18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.

Authors:  Martin Brunner; Oliver Langer; Georg Dobrozemsky; Ulrich Müller; Markus Zeitlinger; Markus Mitterhauser; Wolfgang Wadsak; Robert Dudczak; Kurt Kletter; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.